Navigation Links
CSI-style DNA fingerprinting tracks down cause of cancer spread
Date:7/15/2013

The University of Colorado Cancer Center along with Yale University and the Denver Crime Lab report in the journal PLOS ONE the first proof of cancer's ability to fuse with blood cells in a way that gives cancer the ability to travel, allowing previously stationary cancer cells to enter the bloodstream and seed sites of metastasis around the body. The work used DNA fingerprinting of a bone marrow transplant patient with cancer, along with DNA fingerprinting of the patient's bone marrow donor, to show that subsequent metastatic cancer cells in the patient's body carried parts of both genomes, fused together into a hybrid cancer cell.

Metastasis is responsible for the overwhelming majority of cancer deaths and there are many theories as to how it occurs, but the problem remains yet unsolved. John Pawelek, PhD, at Yale has pointed out that the combination of a cancer cell with a blood cell could explain how a cancer cell acquires the ability to move through the body. The problem is there has been no way to prove this through genetic analyses of the tumor cells they are too similar to the patient's non-tumor cells and so you can't tell if the mutations that allow a cancer cell to travel arose in the cell itself or through fusion with another source.

"One night on a bus ride returning from a conference, John pointed out that, in a patient with a bone marrow transplant, the blood cells come from someone else one person with two genomes," says Richard Spritz, MD, investigator at the CU Cancer Center and professor of pediatrics at the CU School of Medicine. "He had received a pathology specimen of a melanoma tumor that had metastasized to the brain of a patient who had previously received a bone marrow transplant from his brother, and he asked me whether, as a collaboration, we could distinguish between the donor and patient genomes in a cancer cell? I knew that one of the best ways to accomplish this was by DNA fingerprinting."

And so began a wide-reaching collaboration to include, among others, Greggory LaBerge, PhD, who had earned his doctorate in the Spritz lab and was now Director of the Denver Police Department Forensics and Evidence Division.

"This is one of the first instances I know of in which forensic technology has been used to support basic science," Spritz says. "John isolated metastatic cancer cells using technology available at the CU Cancer Center, and Greg did DNA fingerprinting. Between Yale, CU, and the Denver Crime Lab, this is really a remarkable collaboration." After much dedicated work to this single tumor, they found that the entire tumor was populated by cancer cell hybrids with genomes containing both donor and patient DNA.

"Is fusion the mechanism that allows all cancer cells to travel? It's too early to tell, but research toward answering this question is ongoing," Spritz says. He points out that fusion leading to metastasis is likely to be at least somewhat common, as they found this mechanism in the first case they tested. "Of course it could be a fluke," he says. "But I don't think so."

"The finding could have major implications for the treatment of metastatic cancers of many kinds. It really focuses your thinking if traveling tumor cells essentially think they are blood cells, that means we might be able to focus approaches to attack them," Spritz says.


'/>"/>

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Source:Eurekalert

Related biology news :

1. Metabolic fingerprinting: Using proteomics to identify proteins in gymnosperm pollination drops
2. Chemical fingerprinting tracks the travels of little brown bats
3. lobSTR algorithm rolls DNA fingerprinting into 21st century
4. Geology tracks eruptions, earthquakes, erosion, extinctions & more
5. Sequencing tracks animal-to-human transmission of bacterial pathogens
6. New DNA-method tracks fish and whales in seawater
7. Molecular spectroscopy tracks living mammalian cells in real time as they differentiate
8. New technology tracks sparrow migration for first time from California to Alaska
9. U of T-led study cracks universal RNA code, suggests a new cause for autism
10. H7N9 influenza: History of similar viruses gives cause for concern
11. Less haze in Singapore as the cause becomes clearer and more complex
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Mar. 23, 2017 Research and Markets has ... Analysis & Trends - Industry Forecast to 2025" report to ... ... a CAGR of around 8.8% over the next decade to reach ... analyzes the market estimates and forecasts for all the given segments ...
(Date:3/20/2017)... HANOVER, Germany , March 20, 2017 At ... Hamburg -based biometrics manufacturer DERMALOG. The Chancellor came to the ... Japan is this year,s CeBIT partner country. At the largest ... important biometrics in use: fingerprint, face and iris recognition as well as ... ...
(Date:3/9/2017)... Australia , March 9, 2017 ... the prestigious World Lung Imaging Workshop at the University ... , was invited to deliver the latest data to ... globally recognised event brings together leaders at the forefront ... developments in lung imaging. "The quality ...
Breaking Biology News(10 mins):
(Date:3/28/2017)... ... March 28, 2017 , ... ... fully-certified hygienic SWB805 MultiMountTM weigh modules. These weigh modules are designed according ... National Sanitation Foundation (NSF). , As fully integrated weighing solutions, SWB805 MultiMount ...
(Date:3/27/2017)... Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics ... of foodborne pathogens,  today announced that Mary Duseau , ... Convention on March 29 at 9:50am ET. The conference will ... About Roka Bioscience ... Roka Bioscience is a molecular diagnostics ...
(Date:3/27/2017)... Infectex Ltd., a Russian portfolio company of Maxwell Biotech Venture Fund (MBVF), today ... standard drug therapy regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 is a ... ) and the US National Institutes of Health. Continue ... ... ...
(Date:3/27/2017)... ... March 27, 2017 , ... PMG Research is pleased to announce ... by The Conference Forum in Boston on April 3-4, 2017. The CTC conference focuses ... trial outcomes and bring them closer to the patient. Clinical Trial Collaborations also will ...
Breaking Biology Technology: